“World in motion” – emulsion adjuvants rising to meet the pandemic challenges
Derek T. O’Hagan(GlaxoSmithKline (United States)), Giuseppe Lofano(GlaxoSmithKline (United States))
Cited by 104
Related Papers
Advances in vaccine adjuvants
|Nature Biotechnology|1999|507
Recent Advances in Vaccine Adjuvants
|Pharmaceutical Research|2002|242